A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease

Conditions:   Non-alcoholic Fatty Liver Disease;   Obesity Interventions:   Drug: BI 3006337;   Drug: Placebo matching BI 3006337 Sponsor:   Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials